Health Care · Services-Health Services

PRVA Privia Health Group, Inc. SEC Filings & Insider Trading Activity 2026

company
CIK 175965577 filings
Russell 2000

PRVA at a glance

Privia Health Group, Inc. (PRVA, SEC CIK 1759655) filed its latest 10-K annual report on February 27, 2026, a 10-Q quarterly report on November 5, 2026, an 8-K current report on November 18, 2026 and Form 4 insider filings as recently as September 3, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), Privia Health Group, Inc. (PRVA) reported revenue of $2.1 billion (up 22.3% from FY2024) and net income of $22.9 million. Diluted EPS was $0.18.
  • As of September 30, 2026, 30 institutional investment managers tracked by SignalX reported holding Privia Health Group, Inc. (PRVA) shares worth $1.1 billion in 13F-HR filings.
  • The most recent insider open-market sale reported on Form 4 was by Mountcastle David on July 9, 2026 of 21,275 shares at $27.67 per share.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$2.1B
+22.3% vs prior year
Insiders · 90 days
0 buys · 0 sells
No open-market trades
13F holders
30 funds
$1.1B · −2 vs prior quarter
Latest 8-K
Nov 18, 2026
Item 7.01

AI 10-K Annual Report Analysis

Latest 10-K, fiscal year ended Dec 31, 2025

Full analysis →

Business Overview

  • Core business: technology-driven physician enablement platform combining regional medical group partnership with provider autonomy, focused on value-based care (VBC) and provider workflow optimization
  • New emphasis: expansion of Privia Women’s Health and Pediatrics platforms and growth in virtual health services (4.7M virtual visits by 1.5M patients in 2025)
  • Strategic shift: accelerated transition of markets from fee-for-service (FFS) to value-based care, increasing attributed risk lives and emphasizing direct contracting with payers and employers
  • Quantitative highlights: 5,380 Privia Providers across 1,300+ locations serving 5.8M patients; 10 ACOs serving 298,000 Medicare beneficiaries in 2025, with $233.1M shared savings in 2024 (32% YoY increase)
  • Noteworthy: Privia achieved per capita cost savings 8%-35% below median MSSP and FFS Medicare benchmarks, reflecting strong cost control in government programs

Risk Factors

  • Cybersecurity incident risk with potential to compromise patient and business data, cause operational disruption, and trigger costly remediation and liability
  • Board-level oversight of cybersecurity risks involving CISO with 15+ years health IT leadership, ensuring monthly updates to executive leadership
  • Operational risk from reliance on third-party vendors and complex multi-tiered access controls managed by a dedicated Third Party Access Committee
  • Potential reputational and legal harm from failure to manage evolving cybersecurity threat landscape through active Cybersecurity Incident Response Team
  • No disclosed financial leverage, market disruption, geopolitical, or specific regulatory risks in this section

Management Discussion & Analysis

  • Operating lease expense $3.2M in 2025 vs $2.8M in 2024 and $2.7M in 2023
  • Administrative service rebates $3.5M in 2025, $1.8M in 2024, $2.7M in 2023
  • No off-balance sheet obligations as of December 31, 2025
  • Revenue recognition based on FFS-patient care, administrative services, and VBC contracts including capitation, shared savings, and PMPM models

AI summary of the PRVA 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Management Discussion & Analysis

  • Revenue $657.0M, up 13.2% YoY from $580.4M, driven by FFS patient care growth
  • Care Margin 21.0% vs 21.6% YoY, while Adjusted EBITDA Margin 29.4% vs 30.5%
  • Best line FFS patient care: $433.1M, up 22.8%; weakest shared savings: $68.8M, down 13.9%
  • Cash $446.3M; operating cash flow turned negative at $19.4M vs $35.9M provided YoY
  • Near-term liquidity adequate; headwind from shared-savings timing and settlements

Risk Factors

  • No material changes to risk factors disclosed in the latest Annual Report
  • Key carried-forward risks not specified in the quarterly filing

AI summary of the PRVA 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 18, 2026Full analysis →

Item 7.01: Regulation FD Disclosure

  • Press release announces Privia’s 2025 Medicare Shared Savings Program performance
  • Updated full-year 2026 guidance provides investors with revised operating outlook

Item EX-99.1: Item EX-99.1

  • 2025 MSSP shared savings reached $374.0M, up 59.7% year over year across ten ACOs
  • ACOs managed over $4.0B of benchmark spend for more than 297,000 Medicare beneficiaries
Filed Nov 5, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Q3 2026 financial results announced for the quarter ended September 30, 2026
  • Full revenue, earnings, guidance and operating metrics available in Exhibit 99.1, the attached earnings release

Item EX-99.1: Item EX-99.1

  • Q3 revenue $657.0M, up 13.2%, with operating income $20.5M, up 42.6%, and net income $13.5M, up 96.6%
  • YTD net income $25.6M, up 85.9%, and Adjusted EBITDA $114.7M, up 21.9%, supporting stronger 2026 earnings momentum
Filed Aug 18, 2026Full analysis →

Item EX-99.1: Item EX-99.1

  • Opella Ernest, M.D. appointed director effective September 1, 2026
  • Compliance Committee appointment strengthens clinical and value-based care oversight

Item 5.02: Departure/Appointment of Directors or Principal Officers

  • Opella Ernest, M.D. joins Privia Health’s Board as an independent Class III director effective September 1, 2026
  • Compliance Committee appointment adds physician expertise to board oversight

AI summaries of PRVA 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for PRVA

Don't miss the next PRVA filing

  • Alerts as it files. A push when PRVA files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut PRVA, by share count.
  • Ask anything. An AI agent that reads every PRVA filing and answers with sources.

PRVA alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Ernest Opella FinleyASep 1, 2026-
Mountcastle DavidSellJul 9, 2026$27.67
Mountcastle DavidSellJul 7, 2026$27.57
Morris Matthew ShawnMJul 6, 2026-
Morris Matthew ShawnSellJul 6, 2026$27.24
Morris Matthew ShawnMJul 6, 2026$2.00
Mountcastle DavidSellJul 2, 2026$27.50
Morris Matthew ShawnMJul 2, 2026$2.00

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue$1.7B$1.7B$2.1B
Operating Income$20.6M$17.0M$34.2M
Net Income$23.1M$14.4M$22.9M
Op. Margin1.2%1.0%1.6%
Net Margin1.4%0.8%1.1%
Balance Sheet
Total Assets-$1.1B$1.4B
Equity$561.4M$635.2M$737.2M
ROE4.1%2.3%3.1%
Per Share
EPS$0.19$0.11$0.18
Cash Flow
Operating CF-$109.3M$163.4M
CapEx$113K--

Source: XBRL data in Privia Health Group, Inc. (PRVA)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate PRVA share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
PRVA shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202630$1.14B
Q2 202632$1.75B
Q1 202632$1.36B
Q4 202532$1.51B
Q3 202532$1.62B
Q2 202530$1.48B
Q1 202527$1.13B
Q4 202425$915.2M
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 240 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

PRVA filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
8-KNov 18, 2026Analysis-
10-QNov 5, 2026Analysis
8-KNov 5, 2026Analysis-
SC 13DSep 8, 2026-
4Sep 3, 2026--
8-KAug 18, 2026Analysis-
10-QAug 6, 2026Analysis
8-KAug 6, 2026Analysis-
4Jul 13, 2026--
4Jul 9, 2026--
8-KJul 7, 2026Analysis-
4Jul 7, 2026--
4Jul 7, 2026--
4Jul 2, 2026--
4Jun 30, 2026--
4Jun 30, 2026--
4May 22, 2026-
8-KMay 22, 2026Analysis
4May 22, 2026-
4May 22, 2026-
4May 22, 2026-
4May 22, 2026-
4May 22, 2026-
4May 22, 2026-
4May 22, 2026-

Related Health Care companies

All Health Care →

PRVA SEC filings: frequently asked questions

Which institutions hold PRVA stock?

As of September 30, 2026, the largest Privia Health Group, Inc. (PRVA) holders among the 13F filers tracked by SignalX were BlackRock ($446.0 million), Vanguard Portfolio Management LLC ($133.8 million), Vanguard Capital Management LLC ($109.1 million), State Street Corp ($101.3 million), BNY Mellon ($54.8 million). 13F-HR reports are filed up to 45 days after each quarter ends.

What was PRVA's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), Privia Health Group, Inc. (PRVA) reported revenue of $2.1 billion (up 22.3% from FY2024) and net income of $22.9 million. Diluted EPS was $0.18. The figures come from the XBRL data in the 10-K.

What are the main risks in PRVA's latest 10-K?

In the 10-K filed February 27, 2026, Privia Health Group, Inc. (PRVA) flagged: Cybersecurity incident risk with potential to compromise patient and business data, cause operational disruption, and trigger costly remediation and liability. Board-level oversight of cybersecurity risks involving CISO with 15+ years health IT leadership, ensuring monthly updates to executive leadership. (AI summary of the Risk Factors section.)

What did PRVA report in its latest 8-K?

Privia Health Group, Inc. (PRVA) filed an 8-K on November 18, 2026 reporting Item 7.01 (Regulation FD Disclosure). Press release announces Privia’s 2025 Medicare Shared Savings Program performance.

What are the latest PRVA SEC filings?

Privia Health Group, Inc. (PRVA) filed its latest 10-K annual report on February 27, 2026, a 10-Q quarterly report on November 5, 2026, an 8-K current report on November 18, 2026 and a Form 4 insider filing on September 3, 2026.

What is PRVA's SEC CIK number?

Privia Health Group, Inc. (PRVA)'s SEC Central Index Key (CIK) is 1759655. EDGAR lists every PRVA filing under that number.

Ask anything about PRVA

The research agent reads PRVA's filings, financials, insider trades and 13F holders, then answers with sources.